Home
>
US Stocks
>
Esperion Therapeutics Inc.
Esperion Therapeutics Inc.
ESPR

Esperion Therapeutics Inc.

$9.1330.89%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
9.39
Today Low/High
9.13 / 9.48
52 Week Low/High
$13.6 / $40.2
Market Cap
$403.24M

Company Details

Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at Esperion is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.
Organisation
Esperion Therapeutics Inc.
Headquaters
Ann Arbor, Michigan, US
Employees
479
Industry
Health Technology
CEO
Timothy Mayleben

Discover more

Frequently Asked Questions

What is Esperion Therapeutics Inc. share price today

Can Indians buy Esperion Therapeutics Inc. shares?

How can I buy Esperion Therapeutics Inc. shares from India?

Can Fractional shares of Esperion Therapeutics Inc. be purchased?

What are the documents required to start investing in Esperion Therapeutics Inc. stocks?

We are a SEBI registered investement advisor